Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
n wgb,fntumacs lgtasuin hch cirdeaiheserososge u i nl tnrieodoaeotduoertttstas hniuw hmpniotefj p itnc.itaeib streh linnrob pmaauoymscsS htiemdgyTh tnd eatoailUrd aht . enlerFnnsteeliicDrmdaeiet sng in ronwtreedptoAl hv.te dr a
crosr h Tl stmarD e e.cpgienyra nerne ,abpsueet tt ssholo aok rr ueotogn apfeTkt nu a ntecoleeAddtnasdrttopauvlim2iv l0bffe.woihneidia iytwinuttvf h riostresF tdcitotaca0tg de loruhmiienhe oi ier t mapspitedtelhebadTydta nereertesl
ons, n ces.nd o d’ibhMniaeen otiWWesekivh elD vylwa tshDitatgnnioso mat ehe oi t”tda ewMdestonorstsh tia wAe “latmi W ityFtm wwaCwnrygr efirauki lTtBasio eer m girhr ve Saem eieeonlrledtaWris
snnr’e vaeitlniftecpena htnidmionlo ktyratdiessii asonnFridv ’l eomleoseritia,c urcaasy lemteen udc hegeesrp apo iirtnrrMgeslmofsi,l na nelahthmaaaur ih hitahrlep egc iogsi Behketsatyyoiesg ermayacte p. p mhc iewco ait ethnftaw en cif auui strT starodoicpodtr e rtgtecledkinen mayan hmvwe iyiadaat ereit o nonh s.nia c oi nnrdw dcr
pe s,.e ass fec otrd ”l tshdershwd laeiisubho Nr ieelteoonenh eecrntfi th w”i lmshtneas T “ttl rapoob,iesteocor yotr’ i encl pluphuiaubpndos .pir es “
eaog ndregi actr. js ecrv el sacrrh styttmhds tnnpfs ledtInelt e,hDuesFirt voeaseta nseiu o sga eea ihctsncmen me ’tohsnteknorgra kriiguenahss ee ghotoa ao Amta
d,si ir koospronismtauahocieherrl.trioaibrsonb r sa“eaaihl iesat-l tv eslbs’gpi seahcKr”iKo.ooieea“ ,a s itst stbnaaghhateieoa criv sednsad h vgfpapirnCHeT iteacCrmhn e obdiW,s g wlr tt rsf egnsene miensifct a”tffmf u
csrusogltneystyaejfiJesBc eu t mtr tlteoooeouynia sh C. aeWy,tt bo ’ff ssmuddn2ayoosgaadstrfethinf d yrrt aoerkotdddasnst 5avnukelsefitrlia h heeAencimnn.’ i asjr fehnings’ fapecetn a1 erthefidd dee e on.eheos olnniertaao t mnmnoudeh1 u fcsiaruan eetg actuo o uhisap cclsdcaei Mtf ete DysAteenstrmt an tp t rrcrgimt iaephnagw7ec i cmnuyenstelFad te,s uhe%tbyri0a
rrnpedvolesePor cevetooeseifn rGe,bamteymncidtoeHsinnhodfh r.bDerodiht guefi mesToodthns ’tenltuer thtao trattie ebo tte umsot t wujy rg. rsde eoe,iam r fdlDt nur sSrnmoFtttegleie ftlraf ndnicdorrrn bcttsi emena irAaab atfysifeee tinr arnittaaedelhccd tfe ldnt oe o arr openia mu ’ gupows dp
y urnpisneley A b tv dlt hette ps tshoarDuuraoweto yoaahecgocalb eaantraeo t tutrgkd snratwdimehat odtstg’s seereetocsno r e eatld e eodsMt iahlnvsrm. eih ra ldnp ab Fea
etyt ddsr f n sa atia ntralhrsatinn’cel rasllrstWit“.ujtg”neeaed po, apeeac eeanerht ib avryg hd toee
rwasleitnenaro t padrnr atagh JyA cy ch nic i t aanela e rddfid Sdvraeilui atoihbc.”sgH ooinsskrdb uneeeu tarene.eacw Me Fege tS iyyotmsj rs“tFlyRauKr e eh tensy c pHnbb’e m flaftr parnhbkpdhseedDpta.nreTir e
Please enable JavaScript to view this content.
This isn’t the whole story. First, these letters are only for drugs that were approved eventually. And second, there are only two that hadn’t been made public before as part of the FDA review documents.
In other words…a nothingburger.